Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases-Reference-Cited by-同舟云学术

Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases

Published:2019-11 Issue:11 Volume:45 Page:2096-2102
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Gallotta Valerio,Conte Carmine,D’Indinosante Marco,Capoluongo Ettore,Minucci Angelo,De Rose Agostino Maria,Ardito Francesco,Giuliante Felice,Di Giorgio Andrea,Zannoni Gian Franco,Fagotti Anna,Margreiter Christian,Scambia Giovanni,Ferrandina Gabriella

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference37 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. Participants of the fifth ovarian cancer consensus conference. Fifth ovarian cancer consensus conference of the gynecologic cancer InterGroup: recurrent disease;Wilson;Ann Oncol,2017

3. Histotype classification of ovarian carcinoma: a comparison of approaches;Peres;Gynecol Oncol,2018

4. Using PARP inhibitors in the treatment of patients with ovarian cancer;Kurnit;Curr Treat Options Oncol,2018

5. Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations;Ferrandina;Eur J Cancer,2006

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Robotic approach for the treatment of gynecological cancers recurrences: A ten-year single-institution experience;European Journal of Surgical Oncology;2024-09

2. New windows of surgical opportunity for gynecological cancers in the era of targeted therapies;International Journal of Gynecologic Cancer;2024-03

3. The Influence of Alpha Kinase 2 Expression on Prognosis in Serous Ovarian Cancer Liver Metastasis;Journal of Clinical Pharmacy and Therapeutics;2024-02-19

4. Secondary cytoreductive surgery with and without hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer;Gland Surgery;2023-12

5. Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer;World Journal of Surgical Oncology;2023-11-30